Alzheimer’s

New data from Alzheimer’s Society, released ahead of its flagship Memory Walk events this Autumn, reveals that 44% of the nation’s pet owners would prefer to take a walk with their four-legged

Two motivated care workers are celebrating after completing a 26-mile charity walk to raise money for the Alzheimer’s Society ahead of Alzheimer’s Awareness Month.

Alzheimer’s Society has been confirmed as official charity partner of The Football Association for the next two football seasons, following a competitive application process.

Research presented at the 2021 Alzheimer’s Association International Conference (AAIC) in Colorado, shows that more must be done to tackle the barriers to recruitment and retention of participants

A team of researchers from the University of Hertfordshire, Leeds Beckett University and the University of Nottingham have been awarded over £300,000 of funding from the Alzheimer’s Society

The scientific publication Nature Medicine has published findings from an international clinical trial (DIAN-TU) testing the potential Alzheimer’s drugs solanezumab and gantenerumab in people with a rare

The US Food and Drug Administration (FDA) has announced that it has granted a licence for the drug aducanumab (known commercially as Aduhelm) in people with Alzheimer’s disease in the US

British hockey legend and Olympic gold medallist Imran Sherwani has revealed he has Alzheimer’s disease.

Imran, 59, who scored two goals in the final as Great Britain’s men’s hockey team won gold at the 1988 Games

The nation’s newfound love for baking has been revealed, with new data from Alzheimer’s Society, ahead of the charity’s Cupcake Day on 17 June, revealing the UK population has whisked

The Dementia Hero Awards 2021 took place virtually this year, and honoured people from all walks of life who have done outstanding things during the pandemic to help people living with or affected by dementia

The UK risks losing ground to other countries in the search for new dementia treatments if it does not make significant changes to the way it runs clinical trials, according a new report from Alzheimer’s Research UK